Analysen von James Gordon
| 04.10.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.08.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.08.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.08.21 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 29.07.21 | MorphoSys Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 28.07.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.06.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.06.21 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 02.06.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 21.05.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.05.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 04.05.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 30.04.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.04.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.04.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.04.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.03.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 17.03.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 16.03.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 09.02.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 09.02.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.02.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.01.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.01.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 15.01.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.12.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 04.12.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.12.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 23.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.10.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.10.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.10.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 30.09.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 29.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.09.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.09.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.08.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 03.08.20 | MorphoSys overweight | JP Morgan Chase & Co. | |